PATENT CLAIM ANALYSIS

Application Number: 16007586
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "212040"]

Abstract:
This invention relates to methods for treating hearing loss associated with loss of cochlear hair cells, e.g., caused by noise exposure, using certain gamma secretase inhibitors, in post-neonatal animals, e.g., adolescents and adults.

Claim (Index 12):
The method of  claim 11 , wherein the gamma secretase inhibitor is LY411575 (N-2((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)-1-alaninamide).

Metadata:
- Claim Count in Document: 5.0
- Percentile: 94.0
- Lexical Diversity: 1.21212
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13130607', '15306657', '14845263', '13877356', '14833919']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7700150586085214
- 35 USC 102 Novelty (BERT): 0.5225520486700801
- Combined Prediction Score: 0.7452687576146773
- Mean Citation Score: 281.19284000000005
- Max Citation Score: 309.41644
- Similarity Product: 201.9174567330432

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test